A detailed history of Paradigm Financial Partners, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 9,666 shares of TMO stock, worth $5.08 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
9,666
Previous 10,434 7.36%
Holding current value
$5.08 Million
Previous $5.77 Million 3.6%
% of portfolio
0.84%
Previous 0.87%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$531.86 - $624.21 $408,468 - $479,393
-768 Reduced 7.36%
9,666 $5.98 Million
Q2 2024

Aug 13, 2024

BUY
$541.52 - $599.02 $299,460 - $331,258
553 Added 5.6%
10,434 $5.77 Million
Q1 2024

May 15, 2024

BUY
$528.82 - $599.43 $102,062 - $115,689
193 Added 1.99%
9,881 $5.74 Million
Q4 2023

Feb 05, 2024

BUY
$431.41 - $532.94 $68,162 - $84,204
158 Added 1.66%
9,688 $5.14 Million
Q3 2023

Oct 12, 2023

BUY
$498.29 - $574.41 $24,914 - $28,720
50 Added 0.53%
9,530 $4.82 Million
Q2 2023

Jul 13, 2023

SELL
$508.46 - $591.13 $88,980 - $103,447
-175 Reduced 1.81%
9,480 $4.95 Million
Q1 2023

Apr 11, 2023

BUY
$535.0 - $604.82 $82,925 - $93,747
155 Added 1.63%
9,655 $5.56 Million
Q4 2022

Jan 27, 2023

BUY
$484.71 - $571.37 $49,925 - $58,851
103 Added 1.1%
9,500 $0
Q3 2022

Nov 09, 2022

BUY
$507.19 - $604.49 $111,074 - $132,383
219 Added 2.39%
9,397 $5.08 Million
Q2 2022

Jul 27, 2022

SELL
$500.9 - $612.21 $3,506 - $4,285
-7 Reduced 0.08%
9,178 $5.08 Million
Q1 2022

May 16, 2022

BUY
$524.0 - $644.92 $141,480 - $174,128
270 Added 3.03%
9,185 $5.4 Million
Q4 2021

Feb 18, 2022

SELL
$569.0 - $667.24 $30.3 Million - $35.5 Million
-53,210 Reduced 85.65%
8,915 $5.95 Million
Q4 2021

Feb 10, 2022

BUY
$569.0 - $667.24 $30.3 Million - $35.6 Million
53,320 Added 605.57%
62,125 $41.5 Million
Q3 2021

Nov 15, 2021

SELL
$509.53 - $609.78 $22,928 - $27,440
-45 Reduced 0.51%
8,805 $5.14 Million
Q2 2021

Aug 12, 2021

BUY
$441.0 - $508.24 $148,176 - $170,768
336 Added 3.95%
8,850 $4.47 Million
Q1 2021

May 14, 2021

SELL
$439.85 - $518.83 $65,097 - $76,786
-148 Reduced 1.71%
8,514 $3.89 Million
Q4 2020

Feb 12, 2021

SELL
$435.06 - $527.66 $77,005 - $93,395
-177 Reduced 2.0%
8,662 $4.33 Million
Q3 2020

Nov 10, 2020

BUY
$359.77 - $441.52 $121,242 - $148,792
337 Added 3.96%
8,839 $3.9 Million
Q2 2020

Aug 14, 2020

BUY
$275.2 - $362.34 $158,515 - $208,707
576 Added 7.27%
8,502 $3.25 Million
Q1 2020

May 08, 2020

SELL
$255.3 - $340.05 $129,181 - $172,065
-506 Reduced 6.0%
7,926 $2.43 Million
Q4 2019

Jan 29, 2020

BUY
$271.93 - $328.04 $16,315 - $19,682
60 Added 0.72%
8,432 $2.74 Million
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $87,249 - $99,264
-325 Reduced 3.74%
8,372 $2.32 Million
Q2 2019

Aug 14, 2019

BUY
$257.51 - $295.55 $96,566 - $110,831
375 Added 4.51%
8,697 $2.55 Million
Q1 2019

May 15, 2019

SELL
$212.17 - $273.72 $4,243 - $5,474
-20 Reduced 0.24%
8,322 $2.28 Million
Q4 2018

Feb 12, 2019

BUY
$208.47 - $251.98 $1.74 Million - $2.1 Million
8,342 New
8,342 $1.87 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $206B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Paradigm Financial Partners, LLC Portfolio

Follow Paradigm Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Financial Partners, LLC with notifications on news.